Table 4.
Non-HDL cholesterol | Overall mortality | Cardiovascular mortality | ||
---|---|---|---|---|
Hazard ratio (95% CI) | p | Hazard ratio (95% CI) | p | |
Age and gender adjusted | ||||
Quartile 1 | 1.612 (0.809–3.210) | 0.175 | 2.717 (0.846–8.726) | 0.093 |
Quartile 2 | Reference | Reference | ||
Quartile 3 | 1.880 (0.971–3.640) | 0.061 | 2.432 (0.747–7.918) | 0.140 |
Quartile 4 | 1.480 (0.747–2.933) | 0.262 | 2.319 (0.713–7.542) | 0.162 |
Multivariate adjusted (1) | ||||
Quartile 1 | 1.835 (0.911–3.696) | 0.089 | 3.180 (0.966–10.470) | 0.057 |
Quartile 2 | Reference | Reference | ||
Quartile 3 | 1.874 (0.950–3.697) | 0.070 | 2.465 (0.736–8.263) | 0.144 |
Quartile 4 | 1.501 (0.741–3.039) | 0.259 | 2.544 (0.758–8.538) | 0.131 |
Multivariate adjusted (2) | ||||
Quartile 1 | 2.081 (0.968–4.475) | 0.061 | 5.545 (1.319–23.315) | 0.019 |
Quartile 2 | Reference | Reference | ||
Quartile 3 | 2.392 (1.121–5.107) | 0.024 | 5.453 (1.169–25.430) | 0.031 |
Quartile 4 | 1.599 (0.706–3.623) | 0.261 | 3.840 (0.793–18.597) | 0.095 |
Values expressed as hazard ratio and 95% confidence interval (CI). Abbreviations are the same as in Table 1.
Multivariate model 1: adjusted for age, gender, smoking, diabetes mellitus, hypertension, coronary artery disease and congestive heart failure, underlying disease of CKD and BMI.
Multivariate model 2: adjusted for age, gender, smoking, diabetes mellitus, hypertension, coronary artery disease and congestive heart failure, underlying disease of CKD, BMI, systolic blood pressure ≧ 140 mmHg, fasting glucose, HbA1C, hemoglobin, eGFR < 30 ml/min/1.73 m2, total calcium, phosphorous, proteinuria, aspirin, ACEI and/or ARB, β-blocker, calcium channel blocker , diuretics and statin and/or fibrate use.